• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于甲型和乙型流感病毒神经氨酸酶蛋白设计肽表位以开发短肽疫苗

Design of peptide epitope from the neuraminidase protein of influenza A and influenza B towards short peptide vaccine development.

作者信息

Sankar Sathish, Ramamurthy Mageshbabu, Suganya Subramanian, Nandagopal Balaji, Sridharan Gopalan

机构信息

Sri Sakthi Amma Institute of Biomedical Research, Sri Narayani Hospital and Research Centre, Sripuram, Vellore - 632055, Tamil Nadu, India.

出版信息

Bioinformation. 2018 May 31;14(5):183-189. doi: 10.6026/97320630014183. eCollection 2018.

DOI:10.6026/97320630014183
PMID:30108413
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6077822/
Abstract

Influenza viruses A and B are important human respiratory pathogens causing seasonal, endemic and pandemic infections in several parts of the globe with high morbidity and considerable mortality. The current inactivated and live attenuated vaccines are not effective. Therefore, it is of interest to design universal influenza virus vaccines with high efficacy. The peptide GQSVVSVKLAGNSSL of pandemic influenza, the peptide DKTSVTLAGNSSLCS of seasonal influenza and the peptide DILLKFSPTEITAPT of influenza B were identified as potential linear cell mediated epitopes. The epitopes predicted by BepiPred (B-cell epitope designer) program was subjected to docking experiment-using HexDock and CABS dock programs. The epitopes of pandemic H1N1 influenza A gave similar score of high affinity in docking. The epitope DKTSVTLAGNSSLCS of seasonal influenza A and epitope DILLKFSPTEITAPT of influenza B had high binding energy. It is further observed that the peptides GQSVVSVKLAGNSSL (pandemic influenza), DKTSVTLAGNSSLCS (seasonal influenza) DILLKFSPTEITAPT (influenza B) are found to interact with some known MHC class II alleles. These peptides have high-affinity binding with known MHC class II alleles. Thus, they have the potential to elicit cell immune response. These vaccines have to be further evaluated in animal models and human volunteers. These findings have application in the development of peptide B-cell epitope vaccines against influenza viruses.

摘要

甲型和乙型流感病毒是重要的人类呼吸道病原体,在全球多个地区引发季节性、地方性和大流行性感染,发病率高且死亡率可观。目前的灭活疫苗和减毒活疫苗效果不佳。因此,设计高效的通用流感病毒疫苗备受关注。大流行性流感的肽段GQSVVSVKLAGNSSL、季节性流感的肽段DKTSVTLAGNSSLCS以及乙型流感的肽段DILLKFSPTEITAPT被确定为潜在的线性细胞介导表位。通过BepiPred(B细胞表位设计器)程序预测的表位,使用HexDock和CABS dock程序进行对接实验。甲型大流行性H1N1流感的表位在对接中给出了相似的高亲和力分数。甲型季节性流感的表位DKTSVTLAGNSSLCS和乙型流感的表位DILLKFSPTEITAPT具有高结合能。进一步观察发现,肽段GQSVVSVKLAGNSSL(大流行性流感)、DKTSVTLAGNSSLCS(季节性流感)、DILLKFSPTEITAPT(乙型流感)与一些已知的II类主要组织相容性复合体(MHC)等位基因相互作用。这些肽段与已知的II类MHC等位基因具有高亲和力结合。因此,它们有引发细胞免疫反应的潜力。这些疫苗必须在动物模型和人类志愿者中进一步评估。这些发现可应用于开发针对流感病毒的肽段B细胞表位疫苗。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ac4/6077822/0691dadfcfc3/97320630014183F1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ac4/6077822/0691dadfcfc3/97320630014183F1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9ac4/6077822/0691dadfcfc3/97320630014183F1.jpg

相似文献

1
Design of peptide epitope from the neuraminidase protein of influenza A and influenza B towards short peptide vaccine development.基于甲型和乙型流感病毒神经氨酸酶蛋白设计肽表位以开发短肽疫苗
Bioinformation. 2018 May 31;14(5):183-189. doi: 10.6026/97320630014183. eCollection 2018.
2
epitope-based vaccine design against influenza a neuraminidase protein: Computational analysis established on B- and T-cell epitope predictions.基于表位的甲型流感病毒神经氨酸酶蛋白疫苗设计:基于B细胞和T细胞表位预测的计算分析
Saudi J Biol Sci. 2022 Jun;29(6):103283. doi: 10.1016/j.sjbs.2022.103283. Epub 2022 Apr 21.
3
Universal H1N1 influenza vaccine development: identification of consensus class II hemagglutinin and neuraminidase epitopes derived from strains circulating between 1980 and 2011.通用 H1N1 流感疫苗的研发:从 1980 年至 2011 年流行的毒株中鉴定出的 II 类血凝素和神经氨酸酶的共有表位。
Hum Vaccin Immunother. 2013 Jul;9(7):1598-607. doi: 10.4161/hv.25598. Epub 2013 Jul 11.
4
B cell epitopes in the intrinsically disordered regions of neuraminidase and hemagglutinin proteins of H5N1 and H9N2 avian influenza viruses for peptide-based vaccine development.用于基于肽的疫苗开发的H5N1和H9N2禽流感病毒神经氨酸酶和血凝素蛋白内在无序区域中的B细胞表位
J Cell Biochem. 2019 Oct;120(10):17534-17544. doi: 10.1002/jcb.29017. Epub 2019 May 20.
5
Conservation and diversity of influenza A H1N1 HLA-restricted T cell epitope candidates for epitope-based vaccines.甲型流感 H1N1 人类白细胞抗原限制性 T 细胞表位候选物的保守性和多样性,用于基于表位的疫苗。
PLoS One. 2010 Jan 18;5(1):e8754. doi: 10.1371/journal.pone.0008754.
6
Protection against H1N1 influenza challenge by a DNA vaccine expressing H3/H1 subtype hemagglutinin combined with MHC class II-restricted epitopes.表达 H3/H1 亚型血凝素与 MHC Ⅱ类限制性表位的 DNA 疫苗对 H1N1 流感的保护作用。
Virol J. 2010 Dec 7;7:363. doi: 10.1186/1743-422X-7-363.
7
Alternative Strategy for a Quadrivalent Live Attenuated Influenza Virus Vaccine.四价活流感病毒疫苗的替代策略。
J Virol. 2018 Oct 12;92(21). doi: 10.1128/JVI.01025-18. Print 2018 Nov 1.
8
Design of an Epitope-Based Peptide Vaccine Against the Major Allergen Amb a 11 Using Immunoinformatic Approaches.基于表位的 Amb a 11 主要过敏原肽疫苗的免疫信息学设计。
Protein J. 2022 Apr;41(2):315-326. doi: 10.1007/s10930-022-10050-z. Epub 2022 Apr 1.
9
Vaccination with Recombinant Parainfluenza Virus 5 Expressing Neuraminidase Protects against Homologous and Heterologous Influenza Virus Challenge.接种表达神经氨酸酶的重组副流感病毒5可抵御同源和异源流感病毒攻击。
J Virol. 2017 Nov 14;91(23). doi: 10.1128/JVI.01579-17. Print 2017 Dec 1.
10
Bursal peptide BP-IV as a novel immunoadjuvant enhances the protective efficacy of an epitope peptide vaccine containing T and B cell epitopes of the H9N2 avian influenza virus.囊泡肽 BP-IV 作为一种新型免疫佐剂增强了含有 H9N2 禽流感病毒 T 细胞和 B 细胞表位的抗原肽疫苗的保护效力。
Microb Pathog. 2021 Sep;158:105095. doi: 10.1016/j.micpath.2021.105095. Epub 2021 Jul 16.

引用本文的文献

1
Molecular characterization of the neuraminidase gene of virus in Northern Iran.伊朗北部病毒神经氨酸酶基因的分子特征分析
Virusdisease. 2023 Mar;34(1):21-28. doi: 10.1007/s13337-022-00806-7. Epub 2023 Feb 14.
2
Influenza B: Prospects for the Development of Cross-Protective Vaccines.乙型流感:开发交叉保护疫苗的前景。
Viruses. 2022 Jun 17;14(6):1323. doi: 10.3390/v14061323.
3
epitope-based vaccine design against influenza a neuraminidase protein: Computational analysis established on B- and T-cell epitope predictions.

本文引用的文献

1
Novel Platforms for the Development of a Universal Influenza Vaccine.新型平台助力通用型流感疫苗研发。
Front Immunol. 2018 Mar 23;9:600. doi: 10.3389/fimmu.2018.00600. eCollection 2018.
2
Universal type/subtype-specific antibodies for quantitative analyses of neuraminidase in trivalent influenza vaccines.通用型/亚型特异性抗体用于定量分析三价流感疫苗中的神经氨酸酶。
Sci Rep. 2018 Jan 18;8(1):1067. doi: 10.1038/s41598-017-18663-6.
3
Low influenza vaccine effectiveness and the effect of previous vaccination in preventing admission with A(H1N1)pdm09 or B/Victoria-Lineage in patients 60 years old or older during the 2015/2016 influenza season.
基于表位的甲型流感病毒神经氨酸酶蛋白疫苗设计:基于B细胞和T细胞表位预测的计算分析
Saudi J Biol Sci. 2022 Jun;29(6):103283. doi: 10.1016/j.sjbs.2022.103283. Epub 2022 Apr 21.
4
Epidemic situation of the complex seasonality of imported influenza A and B virus transmission in Guangxi ports of China.中国广西港口地区输入性 A、B 型流感病毒传播的复杂季节性流行情况。
Turk J Med Sci. 2021 Jun 28;51(3):1021-1026. doi: 10.3906/sag-2008-63.
2015/2016 流感季节,60 岁及以上人群中,流感疫苗对 A(H1N1)pdm09 或 B/维多利亚系的预防效果较低,且既往接种对预防该病毒感染入院的效果也不佳。
Vaccine. 2017 Dec 19;35(52):7331-7338. doi: 10.1016/j.vaccine.2017.10.100. Epub 2017 Nov 8.
4
Contemporary H3N2 influenza viruses have a glycosylation site that alters binding of antibodies elicited by egg-adapted vaccine strains.当代 H3N2 流感病毒具有糖基化位点,该位点改变了由适应鸡蛋的疫苗株诱导的抗体的结合。
Proc Natl Acad Sci U S A. 2017 Nov 21;114(47):12578-12583. doi: 10.1073/pnas.1712377114. Epub 2017 Nov 6.
5
Effectiveness of influenza vaccines in preventing severe influenza illness among adults: A systematic review and meta-analysis of test-negative design case-control studies.流感疫苗预防成人重症流感疾病的效果:基于病例对照研究的测试阴性设计的系统评价和荟萃分析。
J Infect. 2017 Nov;75(5):381-394. doi: 10.1016/j.jinf.2017.09.010. Epub 2017 Sep 18.
6
Influenza Vaccine Effectiveness in the United States during the 2015-2016 Season.2015 - 2016年流感季节美国流感疫苗的有效性
N Engl J Med. 2017 Aug 10;377(6):534-543. doi: 10.1056/NEJMoa1700153.
7
Molecular features of influenza A (H1N1)pdm09 prevalent in Mexico during winter seasons 2012-2014.2012 - 2014年冬季在墨西哥流行的甲型H1N1流感病毒(pdm09)的分子特征
PLoS One. 2017 Jul 10;12(7):e0180419. doi: 10.1371/journal.pone.0180419. eCollection 2017.
8
A clinical approach to the threat of emerging influenza viruses in the Asia-Pacific region.应对亚太地区新型流感病毒威胁的临床方法。
Respirology. 2017 Oct;22(7):1300-1312. doi: 10.1111/resp.13114. Epub 2017 Jul 5.
9
BepiPred-2.0: improving sequence-based B-cell epitope prediction using conformational epitopes.BepiPred-2.0:利用构象表位改进基于序列的 B 细胞表位预测。
Nucleic Acids Res. 2017 Jul 3;45(W1):W24-W29. doi: 10.1093/nar/gkx346.
10
Evolution of the neuraminidase gene of seasonal influenza A and B viruses in Thailand between 2010 and 2015.2010年至2015年间泰国季节性甲型和乙型流感病毒神经氨酸酶基因的演变
PLoS One. 2017 Apr 14;12(4):e0175655. doi: 10.1371/journal.pone.0175655. eCollection 2017.